Dr Emily Parker explains the importance of the new RCPCH position statement on air pollution and its relevance to healthcare ...
Professor Xenofon Baraliakos, EULAR president-elect, discusses personalised treatment and other challenges and opportunities ...
Professor Antonio Almeida has been at the forefront of clinical haematology for more than 20 years and last year he became president of the European Hematology Association (EHA). Speaking to Julie ...
A second interim analysis of the KEYNOTE-671 trial has shown that adding perioperative pembrolizumab to neoadjuvant chemotherapy for early-stage non-small-cell lung cancer (NSCLC) is effective and ...